Test Price
2,800 AED✅ Home Collection Available
CHD2 Gene Epileptic Encephalopathy, Childhood‑Onset Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CHD2 للاعتلال الدماغي الصرعي في مرحلة الطفولة في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
DHA TRUSTAccuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
PREMIUMPremium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM daily).
CLINICALClinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA‑licensed specialists.
INSURANCEInsurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الفحص الجيني CHD2 يهدف إلى تشخيص الاعتلال الدماغي الصرعي المبكر عند الأطفال بدقة تصل إلى 99.9% وفقًا لإرشادات هيئة الصحة بدبي.
Regulatory Compliance: This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors’ Consent), UAE PDPL (Data Privacy), and is delivered under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical Overview
The CHD2 gene test identifies pathogenic variants causing childhood‑onset epileptic encephalopathy, a severe neurological disorder marked by early‑onset seizures, developmental delay, and often drug‑resistant epilepsy. This NGS‑based analysis provides comprehensive coverage of the entire coding region and splice sites, enabling a definitive molecular diagnosis and personalised treatment strategies.
| Features | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) with Sanger confirmation | Single‑gene Sanger sequencing (full gene) |
| Coverage | Entire coding region + 20 bp exon‑intron boundaries | Coding region (may miss deep intronic variants) |
| Analytical Sensitivity | 99.9% | ~95% (depending on GC‑rich regions) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Accreditation | ISO 9001:2015, DHA‑licensed facility | May lack UAE‑specific accreditation |
Physician Insight & Safety Protocol
“A positive CHD2 result must be interpreted alongside the child’s electroclinical phenotype; I always correlate genetic findings with EEG and video‑telemetry data. As a clinician who has walked this path with countless families, I understand the anxiety a diagnosis brings—we ensure every report is accompanied by a dedicated counselling session. Never stop antiepileptic drugs abruptly; all changes should be supervised by your treating physician.”
— Dr. PRABHAKAR REDDY, Specialist Paediatric Neurologist, DHA License 61713011
⚠️ Do not discontinue any prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Children in status epilepticus or with uncontrolled, life‑threatening seizures require immediate hospitalisation.
- Patients with known coagulopathy or severe bleeding disorders contraindicating venipuncture.
- Individuals unable to provide the minimum sample volume (1 mL of whole blood).
- RED FLAG: If the child develops respiratory distress, prolonged unconsciousness, or signs of raised intracranial pressure during the wait for results, seek emergency care.
Patient FAQ & Clinical Guidance
Q: What is the CHD2 gene and why is it tested for epileptic encephalopathy?
A: The CHD2 gene encodes a chromatin remodelling protein essential for neuronal development; pathogenic variants cause early‑onset drug‑resistant epilepsy and epileptic encephalopathy.
س: ما هو جين CHD2 ولماذا يتم فحصه للاعتلال الدماغي الصرعي؟
ج: جين CHD2 يشفّر بروتينًا حيويًا لتعديل الكروماتين وتطور الخلايا العصبية، والطفرات فيه تسبب صرعًا مقاومًا للأدوية واعتلالًا دماغيًا مبكرًا.
Q: How is the test performed and what sample is required?
A: The test requires a blood sample (whole blood, extracted DNA, or a drop on an FTA card); a certified phlebotomist can collect it at home.
س: كيف يُجرى الفحص وما العينة المطلوبة؟
ج: الفحص يتطلب عينة دم، أو DNA مستخلص، أو بقعة دم على بطاقة FTA؛ خدمة السحب المنزلي متوفرة عبر ممرض معتمد.
Q: How long does it take to receive results and how accurate is the?
A: Results are typically available in 3–4 weeks with 99.9% analytical sensitivity and specificity, confirmed by orthogonal Sanger sequencing.
س: كم يستغرق ظهور النتائج وما مدى دقتها؟
ج: النتائج تصدر عادةً خلال 3–4 أسابيع بحساسية تحليلية تبلغ 99.9% باستخدام تقنية التسلسل الجيني المتقدم مع تأكيد سانجر.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians